Drug Markets/Rotigotine

Rotigotine

6 NDCs across 1 manufacturer|0 Generic,6 Brand

Rotigotine is used to treat parkinson disease and restless legs syndrome, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on May 9, 2007. In 2024, Medicare Part D spent $90 million on Rotigotine across 78,000 claims for 15,000 beneficiaries.

Rotigotine is available as 6 NDCs from 1 manufacturer (0 generic, 6 brand), with NADAC prices from $28.18 to $28.36 per EAa 1% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

6

0G / 6B

Manufacturers

1

competing in market

Price Spread

$28.18 – $28.36

per EA

7d Activity

420 flat

avg -0.0% WoW · of 6 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Manufacturer Breakdown

1 manufacturer producing ROTIGOTINE

Drug Portfolio

6 NDCs total, 6 shown

Frequently Asked Questions

What is Rotigotine used to treat?

Rotigotine is used to treat parkinson disease and restless legs syndrome, per the National Library of Medicine's MED-RT classification.

How much does Medicare spend on Rotigotine?

In 2024, Medicare Part D spent $90 million on Rotigotine across 78,000 claims for 15,000 beneficiaries.

How many Rotigotine products are on the market?

The Rotigotine drug market contains 6 NDCs from 1 manufacturer — 0 generic and 6 brand products.

What is the price range for Rotigotine?

NADAC reference prices for Rotigotine range from $28.1812 to $28.3555 per EA — a 1% difference between cheapest and most expensive.

Which manufacturers make Rotigotine?

1 manufacturer lists Rotigotine in NADAC. Ranked by number of NDCs, the largest are UCB, Inc. (6).

How has the price of Rotigotine changed recently?

Over the past 7 days, 4 Rotigotine NDCs rose and 2 fell, with a market-wide average change of -0.0%.